Cargando…

Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience

BACKGROUND: Allergic inferior turbinate hypertrophy is one of the most common causes of nasal obstruction. Several surgical methods can be used for the reduction of allergic inferior turbinate hypertrophy refractory to medical management. Herein, we share our experience with a potassium titanyl phos...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayakumar, Sabarinath, Divakaran, Shilpa, Parida, Pradipta Kumar, Gopalakrishnan, Suriyanarayanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OceanSide Publications, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837131/
https://www.ncbi.nlm.nih.gov/pubmed/27103557
http://dx.doi.org/10.2500/ar.2016.7.0151
_version_ 1782427798573416448
author Vijayakumar, Sabarinath
Divakaran, Shilpa
Parida, Pradipta Kumar
Gopalakrishnan, Suriyanarayanan
author_facet Vijayakumar, Sabarinath
Divakaran, Shilpa
Parida, Pradipta Kumar
Gopalakrishnan, Suriyanarayanan
author_sort Vijayakumar, Sabarinath
collection PubMed
description BACKGROUND: Allergic inferior turbinate hypertrophy is one of the most common causes of nasal obstruction. Several surgical methods can be used for the reduction of allergic inferior turbinate hypertrophy refractory to medical management. Herein, we share our experience with a potassium titanyl phosphate (KTP) laser, which is a relatively novel technique for turbinate reduction. OBJECTIVES: To evaluate the efficacy of KTP laser turbinate reduction in terms of symptomatic improvement and its effect on nasal mucociliary clearance. METHODS: This study was conducted in the Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, from November 2012 to July 2013. Thirty patients with inferior turbinate hypertrophy refractory to medical management were selected. A KTP laser was used at 6 W in continuous mode, with a spot size of 0.6–1 mm, and energy delivered through a 400-μm optical fiber. A follow-up was done at 1 week, 1 month, and 3 months. All the values (both by the Sino Nasal Outcome Test scoring system and saccharine transit time) were assessed before surgery and at each follow-up visit. RESULTS: The patients showed significant differences in the symptoms (p < 0.0001) at each follow-up. The mean saccharin transit time showed significant prolongation during the first week and first month after surgery, which indicated adverse effects on the mucociliary system (p < 0.0001). This, however, was a temporary effect, and the mean saccharin time returned to normal limits (17.96 minutes) at the third postoperative month. The mean operative time was 11.62 minutes. The procedure was not associated with any serious intra- or postoperative complications. CONCLUSION: KTP laser turbinate reduction is a safe, effective, and minimally invasive procedure in the treatment of allergic inferior turbinate hypertrophy, with a minimal effect on the nasal mucosa. It can be done as an office procedure, with minimal complications.
format Online
Article
Text
id pubmed-4837131
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher OceanSide Publications, Inc.
record_format MEDLINE/PubMed
spelling pubmed-48371312016-04-27 Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience Vijayakumar, Sabarinath Divakaran, Shilpa Parida, Pradipta Kumar Gopalakrishnan, Suriyanarayanan Allergy Rhinol (Providence) Articles BACKGROUND: Allergic inferior turbinate hypertrophy is one of the most common causes of nasal obstruction. Several surgical methods can be used for the reduction of allergic inferior turbinate hypertrophy refractory to medical management. Herein, we share our experience with a potassium titanyl phosphate (KTP) laser, which is a relatively novel technique for turbinate reduction. OBJECTIVES: To evaluate the efficacy of KTP laser turbinate reduction in terms of symptomatic improvement and its effect on nasal mucociliary clearance. METHODS: This study was conducted in the Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, from November 2012 to July 2013. Thirty patients with inferior turbinate hypertrophy refractory to medical management were selected. A KTP laser was used at 6 W in continuous mode, with a spot size of 0.6–1 mm, and energy delivered through a 400-μm optical fiber. A follow-up was done at 1 week, 1 month, and 3 months. All the values (both by the Sino Nasal Outcome Test scoring system and saccharine transit time) were assessed before surgery and at each follow-up visit. RESULTS: The patients showed significant differences in the symptoms (p < 0.0001) at each follow-up. The mean saccharin transit time showed significant prolongation during the first week and first month after surgery, which indicated adverse effects on the mucociliary system (p < 0.0001). This, however, was a temporary effect, and the mean saccharin time returned to normal limits (17.96 minutes) at the third postoperative month. The mean operative time was 11.62 minutes. The procedure was not associated with any serious intra- or postoperative complications. CONCLUSION: KTP laser turbinate reduction is a safe, effective, and minimally invasive procedure in the treatment of allergic inferior turbinate hypertrophy, with a minimal effect on the nasal mucosa. It can be done as an office procedure, with minimal complications. OceanSide Publications, Inc. 2016 /pmc/articles/PMC4837131/ /pubmed/27103557 http://dx.doi.org/10.2500/ar.2016.7.0151 Text en Copyright © 2016, OceanSide Publications, Inc., U.S.A. This publication is provided under the terms of the Creative Commons Public License ("CCPL" or "License"), in attribution 3.0 unported (Attribution Non-Commercial No Derivatives (CC BY-NC-ND)), further described at: http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode. The work is protected by copyright and/or other applicable law. Any use of the work other then as authorized under this license or copyright law is prohibited.
spellingShingle Articles
Vijayakumar, Sabarinath
Divakaran, Shilpa
Parida, Pradipta Kumar
Gopalakrishnan, Suriyanarayanan
Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title_full Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title_fullStr Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title_full_unstemmed Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title_short Potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: Our experience
title_sort potassium titanyl phosphate laser turbinate reduction in the management of allergic inferior turbinate hypertrophy: our experience
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837131/
https://www.ncbi.nlm.nih.gov/pubmed/27103557
http://dx.doi.org/10.2500/ar.2016.7.0151
work_keys_str_mv AT vijayakumarsabarinath potassiumtitanylphosphatelaserturbinatereductioninthemanagementofallergicinferiorturbinatehypertrophyourexperience
AT divakaranshilpa potassiumtitanylphosphatelaserturbinatereductioninthemanagementofallergicinferiorturbinatehypertrophyourexperience
AT paridapradiptakumar potassiumtitanylphosphatelaserturbinatereductioninthemanagementofallergicinferiorturbinatehypertrophyourexperience
AT gopalakrishnansuriyanarayanan potassiumtitanylphosphatelaserturbinatereductioninthemanagementofallergicinferiorturbinatehypertrophyourexperience